TTLL5 Human Pre-designed siRNA Set A contains three designed siRNAs for TTLL5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTLL6 Human Pre-designed siRNA Set A contains three designed siRNAs for TTLL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTLL7 Human Pre-designed siRNA Set A contains three designed siRNAs for TTLL7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTN Human Pre-designed siRNA Set A contains three designed siRNAs for TTN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTPA Human Pre-designed siRNA Set A contains three designed siRNAs for TTPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTPAL Human Pre-designed siRNA Set A contains three designed siRNAs for TTPAL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTR Human Pre-designed siRNA Set A contains three designed siRNAs for TTR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ttr Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ttr gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ttr Rat Pre-designed siRNA Set A contains three designed siRNAs for Ttr gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTYH1 Human Pre-designed siRNA Set A contains three designed siRNAs for TTYH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTYH2 Human Pre-designed siRNA Set A contains three designed siRNAs for TTYH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TTYH3 Human Pre-designed siRNA Set A contains three designed siRNAs for TTYH3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUB Human Pre-designed siRNA Set A contains three designed siRNAs for TUB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBA1A Human Pre-designed siRNA Set A contains three designed siRNAs for TUBA1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBA1B Human Pre-designed siRNA Set A contains three designed siRNAs for TUBA1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBA1C Human Pre-designed siRNA Set A contains three designed siRNAs for TUBA1C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBA4A Human Pre-designed siRNA Set A contains three designed siRNAs for TUBA4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBA8 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBA8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB1 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB2A Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB2B Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB3 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB4A Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB4B Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB4B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB6 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBB8 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBB8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBD1 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBE1 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBG1 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBGCP2 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBGCP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBGCP3 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBGCP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBGCP4 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBGCP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBGCP5 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBGCP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TUBGCP6 Human Pre-designed siRNA Set A contains three designed siRNAs for TUBGCP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tubulin degrader 1 (Compound 5i) is a BML284 (HY-19987) derivative that is an orally active colchicine-site noncovalent tubulin degradation agent with IC50 values ranging from 0.02 to 0.05 μM against the five tumor cell lines (Hela, HCT116, MCF-7, K562 and Molm-13). Tubulin degrader 1 has antiproliferative activity that effectively suppressed tumor growth[1].

Tubulin inhibitor 41 (Compd D19), a promising anti-GBM (glioblastoma) lead compound and tublin inhibitor with BBB permeability, induces G2/M phase arrest, resulted in cell apoptosis and inhibits the migration of U87 cells[1].

Tubulin inhibitor 42 dose-dependently inhibited the activity of β-microtubulin (IC50 = 3.5 µM).Tubulin inhibitor 42 interferes with microtubule dynamic homeostasis, resulting in the arrest of the cancer cell cycle in the G2/M phase and inducing apoptosis. Tubulin inhibitor 42 significantly inhibits the angiogenic process in vitro and in vivo, preventing vascularization and tumor growth[1].

Tubulin inhibitor 43 has significant antitumor activity. Tubulin inhibitor 43 inhibits the proliferation and growth of cancer cells by inhibiting the activity of β-microtubulin, and finally induces apoptosis[1].

Tubulin polymerization-IN-60 (BF3) is a tubulin polymerization inhibitor with anticancer activity. Tubulin polymerization-IN-60 (BF3) belongs to the colchicine binding site inhibitors (CBSIs) and disturbs cell cycle progression leading to G2/M arrest and apoptosis[1].

Tubulin polymerization-IN-61 (Compound 9a) is a tubulin polymerization inhibitor. Tubulin polymerization-IN-61 destroys the microtubule skeleton, blocks the cell cycle in G2/M phase, induces Apoptosis, and inhibits cancer cell migration and colony formation. Tubulin polymerization-IN-61 shows antitumor activity in vivo against 4T1 xenograft model[1].

Tubulin polymerization/V-ATPase-IN-1 (compound F10) is a Tubulin polymerization/V-ATPase inhibitor. Tubulin polymerization/V-ATPase-IN-1 shows robust antiproliferation activity against four human cancer cell lines, and exerts antiproliferative activity by inhibiting tubulin and V-ATPase. Tubulin polymerization/V-ATPase-IN-1 induces immunogenic cell death in addition to apoptosis, and inhibits tumor growth in an RM-1 homograft model with enhanced T lymphocyte infiltration[1].

Tubulin/HDAC-IN-4 (compound 9n) is a dual Tubulin and HDAC inhibitor with IC50 values of 0.73, 0.43, 0.62, 2.34 µM for HDAC1, HDAC2, HDAC6, HDAC7, respectively. Tubulin/HDAC-IN-4 inhibits the tubulin polymerization by targeting the colchicine binding site. Tubulin/HDAC-IN-4 induces apoptosis and cell cycle arrest at G2/M phase. Tubulin/HDAC-IN-4 induces a significant elevation of intracellular ROS levels. […]

Tubulysin B is a highly cytotoxic peptide and potent microtubule destabilizing agents isolated from the myxobacteria Archangium geophyra and Angiococcus disciformis. Tubulysin B has IC50 values in the picomolar range against many cancer cell lines, including those with multidrug resistant properties[1].Tubulysin B is a cytotoxic activity tubulysin which inhibits tubulin polymerization and leads to cell […]

Tucaresol is an orally bioavailable immunopotentiatory drug that show to enhance T-helper-cell activity, with the induction of increased IL-2 and IFN-γ levels in mice and humans. Tucaresol has anti-HIV effect[1].

Tucaresol is an orally bioavailable immunopotentiatory drug that show to enhance T-helper-cell activity, with the induction of increased IL-2 and IFN-γ levels in mice and humans. Tucaresol has anti-HIV effect[1].

Tucaresol is an orally bioavailable immunopotentiatory drug that show to enhance T-helper-cell activity, with the induction of increased IL-2 and IFN-γ levels in mice and humans. Tucaresol has anti-HIV effect[1].

Tucaresol is an orally bioavailable immunopotentiatory drug that show to enhance T-helper-cell activity, with the induction of increased IL-2 and IFN-γ levels in mice and humans. Tucaresol has anti-HIV effect[1].

Tucaresol is an orally bioavailable immunopotentiatory drug that show to enhance T-helper-cell activity, with the induction of increased IL-2 and IFN-γ levels in mice and humans. Tucaresol has anti-HIV effect[1].